Ezeamii Victor C, Arinzechi Chukwujindu I, Oghotuoma Oghenemaro O, Umoudoh Uwakmfonabasi, Adebayo Afolake A, Nnabude Ogechukwu H, Ajani Taiwo, Ayinde Bolaji, Anyaorah Chinelo, Ojukwu Gift
Public Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, USA.
Internal Medicine, May Pen Hospital, May Pen, JAM.
Cureus. 2025 May 12;17(5):e83957. doi: 10.7759/cureus.83957. eCollection 2025 May.
BACKGROUND: Chronic liver disease (CLD) remains a significant global health concern, with fluctuating mortality trends over the past two decades. This study analyzes age-adjusted CLD mortality rates using data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) from 1999 to 2023, highlighting temporal trends and demographic disparities. METHODS: We conducted a retrospective analysis of CLD mortality rates stratified by year, gender, race, age group, and Hispanicity. Age-adjusted mortality rates were computed using direct standardization, and trends were examined over different periods. RESULTS: Between 1999 and 2006, CLD mortality rates declined from 9.6 to 8.8 per 100,000 population. However, from 2007 onward, mortality rates increased, peaking at 14.5 in 2021, largely driven by the COVID-19 pandemic. Males exhibited consistently higher mortality rates than females. Racial disparities were evident, with American Indian/Alaska Native populations experiencing the highest mortality rates. Age-related trends showed the greatest burden in older adults, while mortality rates in younger populations also rose in recent years. Hispanic individuals demonstrated a significant increase in CLD mortality, particularly post-2010. CONCLUSION: CLD mortality has risen significantly since 2007, with a pronounced peak in 2021. Despite a post-pandemic decline, rates remain above pre-2019 levels. These findings emphasize the significance of customized public health interventions and strategies tackling alcohol use, various metabolic risk factors, and healthcare access, especially for high-risk individuals and populations.
背景:慢性肝病(CLD)仍然是一个重大的全球健康问题,在过去二十年中死亡率呈波动趋势。本研究使用疾病控制与预防中心的广泛流行病学研究在线数据(CDC WONDER)1999年至2023年的数据,分析了年龄调整后的CLD死亡率,突出了时间趋势和人口统计学差异。 方法:我们对按年份、性别、种族、年龄组和西班牙裔分层的CLD死亡率进行了回顾性分析。使用直接标准化计算年龄调整后的死亡率,并在不同时期检查趋势。 结果:1999年至2006年期间,CLD死亡率从每10万人9.6例降至8.8例。然而,从2007年起,死亡率上升,在2021年达到峰值14.5例,主要由新冠疫情驱动。男性的死亡率一直高于女性。种族差异明显,美国印第安人/阿拉斯加原住民的死亡率最高。与年龄相关的趋势显示老年人负担最重,而近年来年轻人群的死亡率也有所上升。西班牙裔个体的CLD死亡率显著增加,尤其是在2010年之后。 结论:自2007年以来,CLD死亡率显著上升,2021年达到明显峰值。尽管疫情后有所下降,但仍高于2019年前的水平。这些发现强调了定制公共卫生干预措施和应对酒精使用、各种代谢风险因素以及医疗保健可及性的策略的重要性,特别是针对高危个体和人群。
Nat Rev Gastroenterol Hepatol. 2024-12
Antioxidants (Basel). 2023-8-22
Int J Mol Sci. 2023-6-25
J Clin Exp Hepatol. 2023
Physiol Behav. 2023-2-1
Dig Liver Dis. 2022-11
Clin Ther. 2022-5
J Physiol. 2022-4
Hepatol Commun. 2021-7